Search Results 1811-1820 of 21542 for biopsy

  1. A Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial - Mayo Clinic

    Have previous trauma to the biopsy site. Have any major, clinically significant medical condition (e.g., within six months of baseline, had myocardial ...

  2. Focal Segmental Glomerulosclerosis Clinical Trials - Mayo Clinic Research

    Another kidney biopsy will not be required as part of the study. Candidates must have failed or be intolerant of prior therapy for their kidney disease. The ...

  3. Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas - Mayo Clinic

    Biopsies can be exempt if deemed by the investigator that the biopsy is not medically feasible for the patient or the patient is unfit for the procedure.

  4. Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung - Mayo Clinic

    "Optical biopsy" using bronchoscopic probe-based confocal endomicrosocopy (pCLE) provides real time images of the autofluorescent elastin scaffold of the ...

  5. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

    Patient must have a diagnosis of chronic phase-CML has been confirmed by a bone marrow aspirate and/or biopsy with ≤ 10 % myeloid blasts (i.e., no ...

  6. Nephrotic Syndrome Study Network - Mayo Clinic

    Scheduled renal biopsy. Exclusion Criteria: Prior solid organ transplant; A clinical diagnosis of glomerulopathy without diagnostic renal biopsy; Clinical ...

  7. Currently, the only way to know if your tumor has one of these mutations is to take a tissue sample or biopsy of one of your tumors. Unfortunately biopsies ...

  8. Acute Liver Failure Clinical Trials - Mayo Clinic Research

    ... Biopsy Rochester, MN. We purpose of this study is to evaluate the ... biopsy for any liver disease. . Mayo Clinic Footer. Request Appointment · Give ...

  9. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

    Biopsy of acute GVHD target organ is strongly recommended but not required. Enrollment should not be delayed for biopsy or pathology results. Patients who ...

  10. Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... biopsy with associated lobular inflammation; Stage 3-4 fibrosis by Ishak score on a liver biopsy; Exclusion of other causes of liver disease including viral ...